Search Ontology:
ChEBI

1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine

Term ID
CHEBI:79097
Synonyms
  • (19R)-25-amino-22-hydroxy-22-oxido-16-oxo-17,21,23-trioxa-22lambda(5)-phosphapentacosan-19-yl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
  • 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine
  • 1-Hexadecanoyl-2-docosahexanoyl-sn-glycero-3-phosphoethanolamine
  • 1-palmitoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine
  • 1-Palmitoyl-2-docosahexanoyl-sn-glycero-3-phosphoethanolamine
  • GPEtn(16:0/22:6)
  • GPEtn(16:0/22:6n3)
  • GPEtn(16:0/22:6w3)
  • GPEtn(38:6)
  • PE(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))
  • PE(16:0/22:6)
  • PE(16:0/22:6n3)
  • PE(16:0/22:6w3)
  • PE(38:6)
  • Phophatidylethanolamine(38:6)
  • Phosphatidylethanolamine(16:0/22:6)
  • Phosphatidylethanolamine(16:0/22:6n3)
  • Phosphatidylethanolamine(16:0/22:6w3)
Definition
A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the acyl substituents at positions 1 and 2 are specified as hexadecanoyl and (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl respectively.
References
  • HMDB:HMDB0008946
  • LIPID_MAPS_instance:LMGP02010095
  • Reaxys:7789266
Ontology
ChEBI  ( EBI )
Relationships
is a type of
has_functional_parent
inverse is_tautomer_of
is_tautomer_of
Phenotype
Phenotype resulting from 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine
Phenotype where environments contain 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine
Phenotype modified by environments containing 1-hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoethanolamine
Human Disease Model